Linde India Acquires 100% Stake in Airtech Cryogenic Gases for Rs. 111.20 Crore to Expand Industrial Gas Business
Acquisition to be completed within eight weeks through cash consideration, enabling Linde India to enhance scale in industrial and medical gases sector
Linde India Limited has approved the acquisition of 100% share capital of Airtech Cryogenic Gases Private Limited for an estimated cash consideration of Rs. 111.20 crore. Airtech, incorporated in 2023, specializes in industrial and medical cryogenic gases with a turnover of Rs. 28.99 crore for nine months of operation. The acquisition aims to strengthen Linde India's core business and scale, with completion expected within eight weeks.
Linde India Limited
Acquisition / Amalgamation / Merger / Demerger
Linde India Limited announced the acquisition of 100% share capital of Airtech Cryogenic Gases Private Limited via a Share Purchase Agreement executed on 13 November 2026. The transaction is valued at an estimated Rs. 111.20 crore in cash and is expected to complete within eight weeks.
Airtech Cryogenic Gases Private Limited, incorporated on 10 April 2023, operates in the industrial and medical gases industry, manufacturing and distributing cryogenic gases from its Air Separation Unit located at Dholka, Gujarat.
The company reported a turnover of Rs. 28.99 crore for nine months of operations ending 2026, with previous fiscal turnovers of Rs. 4.58 lakhs in 2025 and nil in 2024.
No governmental or regulatory approvals are required for this acquisition, and it is not a related-party transaction.
With this acquisition, Airtech will become a wholly-owned subsidiary of Linde India, aiming to strengthen the company's core operations and growth trajectory in the industrial gas sector.
Highlights
- Acquisition of 100% equity shares of Airtech Cryogenic Gases Private Limited.
- Estimated cash consideration of Rs. 111.20 crore, subject to closing adjustments.
- Airtech's turnover for nine months of operation is Rs. 28.99 crore.
- Airtech specializes in industrial and medical cryogenic gases with a unit in Dholka, Gujarat.
- Acquisition expected to complete within eight weeks post-execution of the Share Purchase Agreement.
- No related party interest or regulatory approvals needed for this acquisition.
Key Data Snapshot
What happened
- Linde India acquired 100% equity shares of Airtech Cryogenic Gases Private Limited through a Share Purchase Agreement on 13 November 2026.
- The acquisition was approved by Linde India's board on the same day.
- Airtech will become a wholly-owned subsidiary upon completion of conditions precedent and transaction closing.
Key details
- Airtech operates in industrial and medical cryogenic gases manufacturing and distribution.
- Airtech was incorporated on 10 April 2023 and operates an Air Separation Unit in Dholka, Gujarat.
- Airtech reported a turnover of Rs. 28.99 crore for nine months ending 2026.
- Acquisition consideration is approximately Rs. 111.20 crore payable in cash.
- No governmental or regulatory approvals are needed for this acquisition.
- The transaction is not a related party transaction and involves no promoter group interest.
- The deal is expected to complete within eight weeks of agreement execution.
Background and context
- Airtech had no turnover in FY 2024, Rs. 4.58 lakhs turnover in FY 2025, and significantly increased to Rs. 28.99 crore in the latest nine months ending 2026.
- The acquisition will strengthen Linde India's core business, scale, and growth in industrial gases.
- Linde India is listed on NSE under the ticker LINDEINDIA.
Highlights
- Acquisition of 100% equity shares of Airtech Cryogenic Gases Private Limited.
- Estimated cash consideration of Rs. 111.20 crore, subject to closing adjustments.
- Airtech's turnover for nine months of operation is Rs. 28.99 crore.
- Airtech specializes in industrial and medical cryogenic gases with a unit in Dholka, Gujarat.
- Acquisition expected to complete within eight weeks post-execution of the Share Purchase Agreement.
- No related party interest or regulatory approvals needed for this acquisition.
Disclosures
- SEBI Listing Regulations 2015, Regulation 30
- SEBI Master Circular No. HO/49/14/14(7)2025 -CFD -POD2/I/3762/2026 dated 30 January 2026
No related party transaction
No promoter interest
More News on Acquisition / Amalgamation / Merger / Demerger
View allLatest corporate announcements and market updates in Acquisition / Amalgamation / Merger / Demerger.
Dr. Agarwal’s Health Care Limited Allots Over 1.5 Crore Equity Shares After Merger with Eye Hospital Arm
Dr. Agarwal’s Health Care Limited has issued 1,51,90,373 fully paid equity shares to shareholders of Dr. Agarwal’s Eye Hospital Limited pursuant to their merger, raising its paid-up equity capital to ₹33,22,89,484 comprised of 33,22,89,484 shares of ₹1 each.
Read Full StoryFIH Mauritius Investments Ltd Acquires 3.24% Additional Stake in IIFL Capital Services, Becoming Promoter
FIH Mauritius Investments Ltd acquired 1,20,58,525 equity shares representing 3.24% stake in IIFL Capital Services Limited through an open offer completed on November 18, 2026. This acquisition boosted their total shareholding to 41.28%, making them the promoter of IIFL Capital Services as of November 19, 2026.
Read Full StoryICICI Prudential AMC Secures SEBI Approval to Acquire PMS Business from ICICI Securities
ICICI Prudential Asset Management Company Limited announced receipt of SEBI's approval to acquire the Portfolio Management Services business from ICICI Securities Limited, allowing the progression of the slump sale transaction agreed earlier in 2026.
Read Full Story